增强子
CTCF公司
生物
表观遗传学
基因
增强子rna
遗传学
转录因子
DNA甲基化
增强剂陷阱
结合位点
细胞生物学
基因表达
作者
Jurian Schuijers,John C. Manteiga,Abraham S. Weintraub,Daniel S. Day,Alicia V. Zamudio,Denes Hnisz,Tong Ihn Lee,Richard A. Young
出处
期刊:Cell Reports
[Cell Press]
日期:2018-04-01
卷期号:23 (2): 349-360
被引量:139
标识
DOI:10.1016/j.celrep.2018.03.056
摘要
Transcriptional dysregulation of the MYC oncogene is among the most frequent events in aggressive tumor cells, and this is generally accomplished by acquisition of a super-enhancer somewhere within the 2.8 Mb TAD where MYC resides. We find that these diverse cancer-specific super-enhancers, differing in size and location, interact with the MYC gene through a common and conserved CTCF binding site located 2 kb upstream of the MYC promoter. Genetic perturbation of this enhancer-docking site in tumor cells reduces CTCF binding, super-enhancer interaction, MYC gene expression, and cell proliferation. CTCF binding is highly sensitive to DNA methylation, and this enhancer-docking site, which is hypomethylated in diverse cancers, can be inactivated through epigenetic editing with dCas9-DNMT. Similar enhancer-docking sites occur at other genes, including genes with prominent roles in multiple cancers, suggesting a mechanism by which tumor cell oncogenes can generally hijack enhancers. These results provide insights into mechanisms that allow a single target gene to be regulated by diverse enhancer elements in different cell types.
科研通智能强力驱动
Strongly Powered by AbleSci AI